BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 14699906)

  • 1. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Frequently used beta-blockers and circulating thyroid hormones].
    Custro N; Scafidi V; De Francisci MC
    Minerva Endocrinol; 1986; 11(3):185-9. PubMed ID: 2879217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
    Dotzer F; Gromer H
    Fortschr Med; 1993 Aug; 111(24):382-4. PubMed ID: 8104853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
    Perrild H; Hansen JM; Skovsted L; Christensen LK
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of beta-blockade on platelet function and fibrinolytic activity.
    Winther K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S94-8; discussion S99. PubMed ID: 2481178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of thyrotoxicosis with beta-blocking agents].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative trial of atenolol and propranolol in hyperthyroidism.
    McDevitt DG; Nelson JK
    Br J Clin Pharmacol; 1978 Sep; 6(3):233-7. PubMed ID: 356867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-blocking agents in hyperthyroidism.
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propranolol treatment of thyrotoxicosis].
    Karlberg B
    Lakartidningen; 1970 Dec; 67(50):5917-22. PubMed ID: 4395268
    [No Abstract]   [Full Text] [Related]  

  • 11. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of propranolol and metoprolol in the management of hyperthyroidism.
    Murchison LE; How J; Bewsher PD
    Br J Clin Pharmacol; 1979 Dec; 8(6):581-7. PubMed ID: 391258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
    Sontheimer D; Hitchcock K; Saseen J
    J Fam Pract; 2007 Apr; 56(4):312-4. PubMed ID: 17403332
    [No Abstract]   [Full Text] [Related]  

  • 14. The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
    Levey GS
    Med Clin North Am; 1975 Sep; 59(5):1193-9. PubMed ID: 240093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
    Dimenäs E; Dahlöf C; Olofsson B; Wiklund I
    Br J Clin Pharmacol; 1989 Nov; 28(5):527-34. PubMed ID: 2574052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations between beta blockers and the induction of psoriasis].
    Altomare GF; Gandossi E; Pigatto PD; Polenghi MM
    G Ital Dermatol Venereol; 1987 Oct; 122(10):531-3. PubMed ID: 2895063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic use of beta blockers in gastroenterology. Gastrointestinal iatrogenic diseases caused by beta blocker use].
    De Simone M; Leonardi C; Carbonetti M; Mazzetti di Pietralata M
    Minerva Dietol Gastroenterol; 1985; 31(2):245-52. PubMed ID: 2863787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of essential tremor with special reference to the use of beta-blockers].
    Gerstenbrand F; Klingler D; Poewe W
    Nervenarzt; 1982 Aug; 53(8):435-41. PubMed ID: 6127636
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing angina with beta blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Oct; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of propranolol in thyrotoxicosis.
    Horowitz W; Canary JJ
    N Engl J Med; 1971 Feb; 284(6):333-4. PubMed ID: 4395388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.